Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Raises Price Target to $26
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and raises the price target from $21 to $26.
Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and raises the price target from $21 to $26.